ASP Isotopes (ASPI) is a publicly traded Basic Materials sector company. As of May 21, 2026, ASPI trades at $5.32 with a market cap of $664.14M and a P/E ratio of -2.45. ASPI moved +8.68% today. Year to date, ASPI is -19.57%; over the trailing twelve months it is -24.86%. Its 52-week range spans $2.61 to $14.49. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces ASPI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ASP Isotopes Subsidiary Seeks HALEU Supply with European Partner, Deliveries from 2028: Quantum Leap Energy, a subsidiary of ASP Isotopes, signed a non-binding MOU with a European nuclear technology company to assess a framework for supplying high assay low enriched uranium (HALEU) containing over 10% U-235. The agreement outlines a technical and economic evaluation for delivering HALEU from QLE’s planned conversion and enrichment facilities starting in 2028, scaling quantities through 2036, and extends through December 2030.
| Metric | Value |
|---|---|
| Price | $5.32 |
| Market Cap | $664.14M |
| P/E Ratio | -2.45 |
| EPS | $-2.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.49 |
| 52-Week Low | $2.61 |
| Volume | 25.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $23.85M |
| Net Income | $-159.84M |
| Gross Margin | 14.28% |
1 analysts cover ASPI: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.